News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
730,487 Results
Type
Article (53770)
Company Profile (709)
Press Release (676008)
Section
Business (210718)
Career Advice (3366)
Deals (37382)
Drug Delivery (109)
Drug Development (84741)
Employer Resources (183)
FDA (16964)
Job Trends (16203)
News (360000)
Policy (34582)
Tag
Academia (2785)
Alliances (51423)
Alzheimer's disease (1318)
Approvals (16872)
Artificial intelligence (146)
Bankruptcy (377)
Best Places to Work (12180)
Biotechnology (490)
Breast cancer (130)
Cancer (1164)
Cardiovascular disease (104)
Career advice (2840)
Cell therapy (268)
Clinical research (67028)
Collaboration (416)
Compensation (199)
COVID-19 (2726)
C-suite (106)
Data (1144)
Diabetes (166)
Diagnostics (6546)
Earnings (84040)
Employer resources (158)
Events (119391)
Executive appointments (324)
FDA (17511)
Funding (371)
Gene therapy (201)
GLP-1 (675)
Government (4648)
Healthcare (19759)
Infectious disease (2815)
Inflammatory bowel disease (121)
Interviews (658)
IPO (17221)
Job creations (4455)
Job search strategy (2334)
Layoffs (480)
Legal (8269)
Lung cancer (187)
Manufacturing (200)
Medical device (14134)
Medtech (14139)
Mergers & acquisitions (20221)
Metabolic disorders (457)
Neuroscience (1620)
NextGen Class of 2024 (7238)
Non-profit (4559)
Northern California (1512)
Obesity (262)
Opinion (242)
Patents (109)
People (59882)
Pharmaceutical (137)
Phase I (20913)
Phase II (29553)
Phase III (22173)
Pipeline (464)
Postmarket research (2536)
Preclinical (8943)
Radiopharmaceuticals (258)
Rare diseases (243)
Real estate (6514)
Regulatory (23057)
Research institute (2496)
Resumes & cover letters (536)
Southern California (1335)
Startups (4033)
United States (14370)
Vaccines (636)
Weight loss (208)
Date
Today (137)
Last 7 days (814)
Last 30 days (3957)
Last 365 days (38018)
2024 (34895)
2023 (42210)
2022 (53450)
2021 (58023)
2020 (56461)
2019 (49414)
2018 (37591)
2017 (35519)
2016 (35450)
2015 (41184)
2014 (34208)
2013 (28898)
2012 (30632)
2011 (31019)
2010 (28618)
Location
Africa (977)
Arizona (172)
Asia (43606)
Australia (7342)
California (3512)
Canada (1305)
China (261)
Colorado (156)
Connecticut (169)
Europe (97551)
Florida (472)
Georgia (126)
Illinois (392)
Indiana (215)
Kansas (99)
Maryland (596)
Massachusetts (2847)
Michigan (173)
Minnesota (294)
New Jersey (999)
New York (998)
North Carolina (830)
Northern California (1512)
Ohio (145)
Pennsylvania (863)
South America (1361)
Southern California (1335)
Texas (500)
Washington State (397)
730,487 Results for "basf the chemical company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nucleus Biologics Launches NB-KUL™ DF: A DMSO-Free, Chemically-Defined Cryomedia Revolutionizing Cell and Gene Therapy Cryopreservation
October 15, 2024
·
3 min read
Business
Montai Therapeutics Appoints Renowned Chemical Innovator Larry Hamann to Company’s Board of Directors, Convenes Multidisciplinary Scientific Advisory Board to Inform Strategic Momentum
Montai Therapeutics is expanding its network of renowned scientific and technical advisors with the appointment of Larry Hamann to its Board of Directors and the launch of the company’s Scientific Advisory Board (SAB).
May 29, 2024
·
6 min read
Biotech Bay
Nurix Presents the Discovery and Chemical Structure of First-in-Class CBL-B Inhibitor NX-1607 at the American Chemical Society (ACS) Meeting
Nurix Therapeutics, Inc. (Nasdaq: NRIX) today disclosed the discovery and structure of NX-1607 in the First Time Disclosures session at the American Chemical Society Spring 2024 meeting in New Orleans, LA.
March 20, 2024
·
6 min read
Press Releases
PURE Bioscience Announces Distribution Agreement with Madison Chemical Co., Inc.
October 23, 2024
·
6 min read
Cayman Chemical Expands Molecular Diagnostic Research Offerings Through Partnership with PCRassays.com
Cayman Chemical, a leading supplier of research tools for the life science community, has widened their portfolio to include molecular-based detection kits through a strategic partnership with PCRassays.com.
June 6, 2024
·
2 min read
Business
Oakwood Chemical Announces Strategic Partnership with EMP Biotech GmbH
Oakwood Chemical is thrilled to unveil its collaboration with EMP Biotech GmbH, a move set to streamline the oligo synthesis supply chain.
April 9, 2024
·
2 min read
Genetown
908 Devices Trace Chemical Identification Technology Adopted by European Agencies
908 Devices Inc., a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the latest in international adoption of the MX908 for trace detection and identification of priority drugs and chemical threats.
March 12, 2024
·
5 min read
Press Releases
Alterity Therapeutics Appoints Abby Macnish Niven as Company Secretary
November 19, 2024
·
3 min read
Cayman Chemical Introduces LipidLaunch™, Expands Portfolio of Lipid Nanoparticle Research Tools to Support Advances in RNA Therapies
Cayman Chemical, a leading supplier of research tools for lipid nanoparticles (LNPs), announced today the introduction of LipidLaunch™ research-ready LNPs and reagent kits.
February 20, 2024
·
2 min read
Pharm Country
Verrica Pharmaceuticals Announces that YCANTH™ Receives New Chemical Entity Status and Orange Book Listing from the FDA
Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA) today announced that the Company’s lead product, YCANTH™, has received New Chemical Entity (“NCE”) Status and a listing in the Orange Book from the U.S. Food and Drug Administration (“FDA”), providing a minimum five years of regulatory exclusivity.
March 26, 2024
·
3 min read
1 of 73,049
Next
